2nd Line Metastatic, Stage 4 Patients with Progressive Disease
LungMAP
A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
8940 N. Wood Sage Rd | Peoria, IL 61615-7822